The Allplex™ 2019-nCoV Assay is an in vitro diagnostic (IVD) real-time reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the qualitative detection of SARS-CoV-2 viral nucleic acids. It is a multiplex, real-time PCR assay for simultaneous detection of 3 target genes of SARS-CoV-2 in a single tube. The assay is designed to detect RdRP and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus including SARS-CoV-2.
- Delivers results faster at a lower cost and more accurately
- Delivers accurate results for better patient care and peace of mind
- Automatic Data Analyzer: Easily retrieves results and eliminates interpretation and clerical errors
The Allplex™ 2019-nCoV Assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the Allplex™ 2019-nCoV Assay for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Allplex™ 2019-nCoV Assay for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Allplex™ 2019-nCoV Assay for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.